Evidence map›Paper›PMID 41965630›Full record

ArticleBMC infectious diseases2026

Catheter-associated bacteremia caused by Asaia lannensis in an immunosuppressed patient: a case report.

Thomas M Simonet, Claire Bertelli, Hamza Mraihi, Onya Opota, Laurent Poirel, Frédéric Tissot, Baptiste Lemaire

Abstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Identification and Characterization of aInfection and drug resistance · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Thomas M SimonetLaboratories, Clinique de La Source, Lausanne, Switzerland.
Claire BertelliInstitute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.
Hamza MraihiInfectious Diseases Specialist, Clinique de La Source, Lausanne, Switzerland.
Onya OpotaInstitute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.
Laurent PoirelSwiss National Reference Center for Emerging Antibiotic Resistance, Fribourg, Switzerland.
Frédéric TissotInfectious Diseases Specialist, Clinique de La Source, Lausanne, Switzerland.
Baptiste LemaireLaboratories, Clinique de La Source, Lausanne, Switzerland. b.lemaire@lasource.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAsaia spp. are an environmental Gram-negative bacterial species rarely implicated in human infections. Only a handful of cases have been reported, primarily involving catheter-associated bloodstream infections or infections related to intravenous drug abuse. We present here a case of bacteremia caused by Asaia lannensis in an immunocompromised patient with hairy cell leukemia. CASE PRESENTATION: An 84-year-old man with a history of hairy cell leukemia presented with relapse and was treated with cladribine via a subclavian central venous catheter. The patient developed a febrile episode three weeks after the start of chemotherapy, without hemodynamic instability but with elevated inflammatory markers and a mild erythema at the catheter site. Blood cultures drawn both by venipuncture and from the catheter grew a slow-growing, thin Gram-negative bacillus after prolonged incubation. Conventional identification methods based on biochemical profiling misidentified the bacterium as Serratia fonticola, and MALDI-TOF MS analysis was inconclusive. After initial genus-level identification through 16 S rDNA gene sequencing, whole genome sequencing demonstrated the classification to Asaia lannensis. The same organism was cultured directly from the catheter, confirming the source of infection. Antimicrobial susceptibility testing revealed elevated MICs to most commonly-used antibiotics, including beta-lactams, macrolides, quinolones, and last-resort agents such as colistin and cefiderocol. However, lower minimal inhibitory concentrations were observed for aminoglycosides and tetracyclines, suggesting potential in vitro activity. The patient showed rapid clinical improvement after catheter removal and a short antibiotics course, with no recurrence of fever or hemodynamic deterioration. This clinical observation is singular in that Asaia lannensis was recovered both from blood cultures and directly from the catheter, confirming the device as the source of infection.

conclusionsThis case illustrates the potential of Asaia lannensis to cause clinically-significant infections in immunocompromised patients, particularly those with central venous catheters. It highlights the limitations of conventional microbiological identification techniques when dealing with uncommon environmental pathogens. Catheter removal was crucial to resolution, underscoring the importance of device management in the treatment of catheter-associated bloodstream infections. Clinicians and microbiologists should remain alert to rare opportunistic organisms in patients with indwelling medical devices and consider advanced molecular diagnostics when standard methods fail.

Indexed as

BacteremiaCatheter-Related InfectionsGram-Negative Bacterial InfectionsImmunocompromised HostAged, 80 and overAnti-Bacterial AgentsCentral Venous CathetersHumansMaleMicrobial Sensitivity TestsRNA, Ribosomal, 16SAnti-Bacterial AgentsRNA, Ribosomal, 16SAsaiaBacteremiaBacterialCase reportsCatheter-related infectionsCentral venous cathetersDrug resistanceHairy cellImmunocompromised hostLeukemia

Identifiers

PMID41965630
PMCPMC13196247

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.